Hospital
Upper Valley Medical Center
Upper Valley Medical Center was paid $18.32M by Medicaid between Jan 2018 and Dec 2024, across 215 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 18% of everything it billed.
33Billing provider infoUPPER VALLEY MEDICAL CENTER
TROY, OH 45373
TROY, OH 45373
33aNPI1184638942assigned 07/28/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$18.32M
24GClaims497,438
24DCodes billed215
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#54 of 101
Median peer was paid$22.32M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 83,800 | $2.76M | |
| 2019 | 72,252 | $2.42M | |
| 2020 | 42,907 | $1.86M | |
| 2021 | 17,016 | $780K | |
| 2022 | 17,702 | $646K | |
| 2023 | 152,811 | $5.52M | |
| 2024incomplete | 110,950 | $4.34M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 18% | 12,160 | 9,438 | $3.28M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 28,281 | 25,731 | $3.07M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 24,946 | 21,478 | $2.93M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.9% | 9,838 | 8,433 | $1.26M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.8% | 13,180 | 3,562 | $880K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.5% | 3,776 | 2,971 | $830K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.3% | 2,534 | 2,053 | $599K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.7% | 5,317 | 4,685 | $489K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.4% | 4,167 | 3,355 | $443K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.0% | 1,306 | 1,134 | $361K |
| G0378 | Hospital observation service, per hour | 1.7% | 4,807 | 1,685 | $315K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1.5% | 1,561 | 1,204 | $279K |
203 more codes
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.5% | 2,762 | $270K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.4% | 1,097 | $252K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.3% | 2,833 | $237K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.3% | 2,997 | $234K |
| 80053 | Comprehensive metabolic panel | 1.2% | 22,977 | $226K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 954 | $149K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 336 | $134K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,717 | $131K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 637 | $127K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 801 | $126K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 353 | $118K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 429 | $93K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 179 | $88K |
| 70496 | <1% | 368 | $85K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 4,267 | $85K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,811 | $65K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 255 | $63K |
| 43249 | <1% | 228 | $60K | |
| 84484 | <1% | 11,791 | $57K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,997 | $50K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 689 | $47K |
| 97162 | <1% | 1,315 | $39K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 755 | $38K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,423 | $35K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,009 | $34K |
| 93017 | <1% | 409 | $33K | |
| 72131 | <1% | 492 | $31K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,073 | $31K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 162 | $31K |
| 93970 | <1% | 257 | $30K | |
| 93971 | <1% | 501 | $30K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 135 | $26K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 14,471 | $23K |
| 74018 | <1% | 513 | $22K | |
| 97014 | <1% | 603 | $22K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,043 | $20K |
| 80320 | <1% | 1,715 | $18K | |
| 76642 | <1% | 154 | $18K | |
| 83605 | <1% | 2,408 | $18K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 32 | $17K |
| 71250 | <1% | 268 | $17K | |
| 97161 | <1% | 417 | $15K | |
| 70486 | <1% | 291 | $15K | |
| 76830 | Ultrasound, transvaginal | <1% | 273 | $15K |
| 97012 | <1% | 317 | $13K | |
| 73130 | <1% | 757 | $12K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 33,415 | $11K |
| 0001A | <1% | 351 | $11K | |
| 0002A | <1% | 299 | $10K | |
| 87040 | <1% | 1,555 | $10K | |
| 71045 | Radiologic examination, chest; single view | <1% | 8,744 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 33,527 | $9K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 759 | $9K |
| 97166 | <1% | 249 | $9K | |
| 73630 | <1% | 827 | $8K | |
| 86850 | <1% | 471 | $7K | |
| 73030 | <1% | 559 | $7K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 14 | $7K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 47 | $7K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 48 | $7K |
| 73110 | <1% | 422 | $7K | |
| 86900 | <1% | 598 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,195 | $6K |
| 70491 | <1% | 19 | $6K | |
| 83880 | <1% | 1,405 | $6K | |
| 12001 | <1% | 33 | $5K | |
| 73560 | <1% | 591 | $5K | |
| J3490 | Unclassified drugs | <1% | 3,555 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,390 | $5K |
| 80061 | Lipid panel | <1% | 521 | $5K |
| 72100 | <1% | 92 | $5K | |
| 73610 | <1% | 627 | $5K | |
| 72128 | <1% | 176 | $5K | |
| 81003 | <1% | 15,259 | $4K | |
| 97116 | <1% | 278 | $4K | |
| 70498 | <1% | 355 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 375 | $4K |
| 96376 | <1% | 2,639 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 373 | $4K |
| 85027 | <1% | 1,499 | $4K | |
| 90715 | <1% | 288 | $4K | |
| 82565 | <1% | 431 | $3K | |
| 87070 | <1% | 3,123 | $3K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 16 | $3K |
| 76536 | <1% | 26 | $3K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | <1% | 95 | $3K |
| 82248 | <1% | 12,678 | $3K | |
| 81001 | <1% | 4,883 | $2K | |
| 73590 | <1% | 164 | $2K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 137 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 14,517 | $2K |
| 87510 | <1% | 86 | $2K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 49 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 138 | $2K |
| 81025 | <1% | 7,742 | $2K | |
| 96367 | <1% | 106 | $2K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 62 | $2K |
| 73502 | <1% | 127 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 12,734 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 725 | $2K |
| 87480 | <1% | 86 | $2K | |
| 85379 | <1% | 1,248 | $2K | |
| 88341 | <1% | 39 | $2K | |
| 74178 | <1% | 22 | $2K | |
| 87660 | <1% | 99 | $1K | |
| 85610 | <1% | 3,160 | $1K | |
| 95819 | <1% | 13 | $1K | |
| 83735 | <1% | 2,069 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 387 | $1K |
| 73562 | <1% | 45 | $1K | |
| 83690 | <1% | 10,935 | $1K | |
| 97163 | <1% | 15 | $827.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,306 | $797.62 |
| 87088 | <1% | 2,609 | $797.30 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,397 | $742.08 |
| 87430 | <1% | 3,194 | $695.88 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,831 | $614.18 |
| 82803 | <1% | 1,145 | $604.67 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,363 | $566.83 |
| 83655 | <1% | 12 | $484.68 | |
| J1815 | Injection, insulin, per 5 units | <1% | 497 | $435.62 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,898 | $427.25 |
| 85730 | <1% | 2,113 | $410.79 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 326 | $379.08 |
| 88142 | <1% | 27 | $377.16 | |
| 00731 | <1% | 666 | $371.70 | |
| 77066 | Tomosynthesis, mammo | <1% | 15 | $357.05 |
| 73090 | <1% | 58 | $321.07 | |
| 84439 | <1% | 252 | $291.60 | |
| 86901 | <1% | 598 | $280.73 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 180 | $274.03 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,762 | $268.11 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 527 | $252.63 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,777 | $237.29 |
| 86140 | <1% | 181 | $205.35 | |
| 87077 | <1% | 698 | $197.59 | |
| 84100 | <1% | 286 | $185.11 | |
| 80329 | <1% | 14 | $163.11 | |
| 88342 | <1% | 1,252 | $137.61 | |
| 87186 | <1% | 649 | $136.16 | |
| 82550 | <1% | 382 | $119.93 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,251 | $118.62 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 931 | $96.19 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,298 | $88.23 |
| 84702 | <1% | 379 | $78.17 | |
| 87147 | <1% | 64 | $72.42 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,861 | $65.98 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 109 | $64.56 |
| 74022 | <1% | 71 | $58.42 | |
| J2704 | Injection, propofol, 10 mg | <1% | 4,634 | $54.10 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,163 | $45.37 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 18 | $44.40 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,203 | $43.76 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 444 | $43.09 |
| J3535 | Drug administered through a metered dose inhaler | <1% | 89 | $41.18 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 678 | $38.62 |
| 80143 | <1% | 358 | $36.07 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 563 | $29.47 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 548 | $26.73 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,359 | $24.52 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 425 | $21.48 |
| 84703 | <1% | 44 | $19.45 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,418 | $18.17 |
| 80179 | <1% | 335 | $18.03 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 175 | $16.24 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 475 | $15.15 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 195 | $12.15 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 55 | $11.73 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 147 | $10.73 |
| 76376 | <1% | 16 | $10.65 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 35 | $9.87 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 73 | $8.72 |
| 85652 | <1% | 190 | $7.93 | |
| 91300 | <1% | 603 | $5.21 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 208 | $4.41 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 147 | $4.39 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 39 | $3.04 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,058 | $2.87 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 23 | $1.24 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 451 | $0.35 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 5,269 | $0.00 |
| Q9956 | Injection, octafluoropropane microspheres, per ml | 0% | 117 | $0.00 |
| 93356 | 0% | 434 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 0% | 49 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 48 | $0.00 |
| 00811 | 0% | 126 | $0.00 | |
| 82010 | 0% | 20 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 108 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 0% | 43 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 39 | $0.00 |
| 82805 | 0% | 28 | $0.00 | |
| 00813 | 0% | 325 | $0.00 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 0% | 576 | $0.00 |
| 82150 | 0% | 389 | $0.00 | |
| C1726 | Catheter, balloon dilatation, non-vascular | 0% | 175 | $0.00 |
| 94760 | 0% | 409 | $0.00 | |
| 72170 | 0% | 36 | $0.00 | |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 80 | $0.00 |
| 88304 | 0% | 134 | $0.00 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 0% | 156 | $0.00 |
| 82270 | 0% | 19 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 33 | $0.00 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSNIDER, TIMOTHY (VICE PRESIDENT FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Good Samaritan Hospital & Health Center | Dayton, OH | $2.51M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.